ACTA1 and Hepatic fibrosis: Isochlorogenic acid and chlorogenic acid can inhibit the protein expression of HMGB1 and TLR4, suppress the overexpression of α-SMA in HSCs, and prevent HSCs activation, thereby alleviating liver fibrosis [134,135].